It doesn’t seem possible, but on June 21, 2016, The Crohn’s Infection site will officially be one year old. Join us as we highlight some of the key site features and enter our first site contest. Thanks for coming to the party!
AMAT: Together We Are Stronger
On June 14, 2016, the journal Gut Pathogens released a new study entitled “RHB-104 Triple Antibiotics Combination in Culture is Bactericidal and Should be Effective for Treatment of Crohn’s Disease Associated with Mycobacterium paratuberculosis.” The researchers from the University of Central Florida (including Dr. Saleh Naser) found that the raw active ingredients used in RHB-104 worked together in combination to inhibit the growth of 16 Mycobacterium avium paratuberculosis (MAP) strains and 19 other mycobacterial species.
Fathers
To all of the fathers out there: We hear you and acknowledge your love and strength in whatever health battle you are fighting. We support you. We care.
John Aitken | Mothers
This photo is that of a group of white cells in the blood of a Crohn’s patient. It is literally “One from the heart.”From all of us to all of you,
Happy Mothers Day, and thank you so much for all that you do.
Dietzia: A Potential Probiotic Therapy for Crohn’s Disease
In this age of organic food, chemical free products, farmer’s markets and going green, it’s no wonder that Dietzia spp. C79793-74 is generating great interest among Crohn’s disease patients. After all, if this emerging probiotic therapy could curtail the symptoms of Crohn’s disease as well as, or even better than, conventional therapies but without the side effects, it may well become the future of Crohn’s treatment. While human research and trials need to be completed, Dietzia has shown promise in cattle infected with Johne’s disease.
With new information emerging about this bacterial species, we thought our readers would enjoy this timely overview. We are honored to introduce the man who discovered benefits of Dietzia spp. C79793-74, Dr. Robert E. Click.
MAP and Crohn’s Disease in the News
Some of you may have seen these recent news articles regarding MAP and Crohn’s disease. For those of you who missed it, here’s a brief recap. I particularly enjoyed listening to the two new interviews given by Prof. Thomas Borody.
The MAP Gap Newsletter | April 2016
The Crohns Infection is dedicated to providing the most up-to-date information in our field to assist patients around the world in making informed decisions about their treatment. We are grateful for the support of this community and look forward to taking this journey together.
Here are some of the most recent developments in the area of MAP related Crohn’s Research. Enjoy!
Gilles R. G. Monif, M.D. | How MAP Becomes Crohn’s Disease
Any claim for causation of Crohn’s disease must address four key issues:
- Why the sudden onset of disease in the twentieth century;
- Why its epidemic spread;
- Why limited sites of involvement within the gastrointestinal tract; and
- Why the significant variability with respect to the age of onset.
Dr. Monif addresses these questions and more in this opinion piece published with permission of The International Association for Paratuberculosis.
John Aitken | Endophytes
In the plant world, endophytes exist within plants to perform essential functions in the plant – stimulation of plant immunity, competitive inhibition (making sure there is no room left for an invader) and production of chemicals capable of killing other bacteria (antibiotics). This is a process called “symbiosis.” Symbiosis occurs when two organisms co-exist and one, or both, organisms benefit from the relationship. In plants, endophytes have evolved to be part of the growth mechanisms of the plant. They are found in the roots and in the leaves.
What has this to do with Crohn’s disease?
Gilles R. G. Monif, M.D. | Understanding Crohn’s Disease
A governing principle within the doctrines of international law on food safety is reflected in the words “The importance of the precautionary measures should not be played down on the grounds that the risk is not proven.” The collateral damage from not adhering to the precautionary principle is partially reflected in the numbers. In 1998, the number of Crohn’s disease afflicted individuals numbered 358,000. In 2006, this number was 560,000. In 2010, it was an estimated 800,000. In 2015, crude estimates place the figure above a million.
The 2015 expanded Hruska Postulate states that Crohn’s disease is the interaction of two immune responses to MAP occurring in different time frames. Learn more about these two immune responses and welcome our newest presenter, Gilles R. G. Monif, M.D.